The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis

Gill Webster, Vicky Pearson, Edwin Lim, Nancy Mayo

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Article numberPP1.27
Pages (from-to)NP25
Number of pages1
JournalMultiple Sclerosis
Issue number14
Publication statusPublished - Dec 2015
EventMS Research Australia Progress in MS Research Conference - Melbourne, Australia
Duration: 29 Oct 201530 Oct 2015


  • Myeloid-directed
  • neuroprotection
  • kynurenine/tryptophan
  • growth-factors
  • anti-inflammatory

Cite this